Concepedia

J-P Liou

JL

Statistics

Publications

3

Citations

144

H-Index

3

Active since

2013

Affiliations

National Taiwan University(Current)

Taipei Medical University

J-P Liou is an author at National Taiwan University specializing in pharmacology, medicine, and targeted cancer therapy.

ORCID

Publications per year

2013–2014

3

Publications

3

The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells

M. C. Chen, C. H. Chen, J-C Wang et al. · Cell Death and Disease · 2013 · 78 citations · Full text

, , +17

Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009

I-Ni Hsieh, J-P Liou, H. Y. LEE et al. · Cell Death and Disease · 2014 · 47 citations · Full text

, , +15

Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib

A-C Tsai, J-P Liou, H-C Pai et al. · Cell Death and Disease · 2014 · 19 citations · Full text

, , +15

1–3 of 3